JP2022538148A5 - - Google Patents
Info
- Publication number
- JP2022538148A5 JP2022538148A5 JP2021576970A JP2021576970A JP2022538148A5 JP 2022538148 A5 JP2022538148 A5 JP 2022538148A5 JP 2021576970 A JP2021576970 A JP 2021576970A JP 2021576970 A JP2021576970 A JP 2021576970A JP 2022538148 A5 JP2022538148 A5 JP 2022538148A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- polypeptide chain
- sequence
- chain containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025020882A JP2025081413A (ja) | 2019-06-27 | 2025-02-12 | ｐ５３におけるＲ１７５Ｈ又はＹ２２０Ｃ変異を認識するＴ細胞受容体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962867619P | 2019-06-27 | 2019-06-27 | |
| US62/867,619 | 2019-06-27 | ||
| PCT/US2020/039785 WO2020264269A1 (en) | 2019-06-27 | 2020-06-26 | T cell receptors recognizing r175h or y220c mutation in p53 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025020882A Division JP2025081413A (ja) | 2019-06-27 | 2025-02-12 | ｐ５３におけるＲ１７５Ｈ又はＹ２２０Ｃ変異を認識するＴ細胞受容体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022538148A JP2022538148A (ja) | 2022-08-31 |
| JP2022538148A5 true JP2022538148A5 (enExample) | 2023-06-29 |
| JP7635165B2 JP7635165B2 (ja) | 2025-02-25 |
Family
ID=71662353
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576970A Active JP7635165B2 (ja) | 2019-06-27 | 2020-06-26 | ｐ５３におけるＲ１７５Ｈ又はＹ２２０Ｃ変異を認識するＴ細胞受容体 |
| JP2025020882A Pending JP2025081413A (ja) | 2019-06-27 | 2025-02-12 | ｐ５３におけるＲ１７５Ｈ又はＹ２２０Ｃ変異を認識するＴ細胞受容体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025020882A Pending JP2025081413A (ja) | 2019-06-27 | 2025-02-12 | ｐ５３におけるＲ１７５Ｈ又はＹ２２０Ｃ変異を認識するＴ細胞受容体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12479902B2 (enExample) |
| EP (1) | EP3990481A1 (enExample) |
| JP (2) | JP7635165B2 (enExample) |
| KR (1) | KR20220047969A (enExample) |
| CN (1) | CN114341171A (enExample) |
| AU (1) | AU2020308004B2 (enExample) |
| BR (1) | BR112021026408A2 (enExample) |
| CA (1) | CA3144070A1 (enExample) |
| MX (1) | MX2021015877A (enExample) |
| TW (2) | TW202525841A (enExample) |
| WO (1) | WO2020264269A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019077062A1 (en) * | 2017-10-18 | 2019-04-25 | Vivia Biotech, S.L. | C-CELLS ACTIVATED BY BIT |
| WO2022183167A1 (en) | 2021-02-25 | 2022-09-01 | Alaunos Therapeutics, Inc. | Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof |
| WO2022232599A1 (en) * | 2021-04-30 | 2022-11-03 | Regents Of The University Of Minnesota | Mesothelin-specific t cell receptors and methods of using same |
| WO2022235577A2 (en) * | 2021-05-03 | 2022-11-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | T cell receptors (tcrs) targeting minor histocompatibility antigen ha-1 |
| JP2024517884A (ja) * | 2021-05-07 | 2024-04-23 | アメリカ合衆国 | ｐ５３におけるＣ１３５Ｙ、Ｒ１７５Ｈ又はＭ２３７Ｉ変異を認識するＴ細胞受容体 |
| JP2024540197A (ja) * | 2021-10-29 | 2024-10-31 | ホウ，ヤフェイ | Ｐ５３におけるｒ１７５ｈ変異を認識するｔ細胞受容体およびその用途 |
| US20250145950A1 (en) | 2022-02-01 | 2025-05-08 | Alaunos Therapeutics, Inc. | Methods for Activation and Expansion of T Cells |
| WO2024076692A1 (en) * | 2022-10-05 | 2024-04-11 | Icahn School Of Medicine At Mount Sinai | Heterobifunctional compounds as p53 acetylators |
| WO2024163371A1 (en) * | 2023-01-30 | 2024-08-08 | Fred Hutchinson Cancer Center | Binding proteins specific for mutant p53 and uses thereof |
| WO2024206274A2 (en) | 2023-03-27 | 2024-10-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors targeting y220c or r175h mutation in p53 |
| WO2024220520A2 (en) * | 2023-04-21 | 2024-10-24 | Board Of Regents, The University Of Texas System | T-cell receptors targeting her2 and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8034334B2 (en) | 2002-09-06 | 2011-10-11 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| MX375379B (es) | 2014-05-29 | 2025-03-06 | Us Health | Receptores de celulas t anti - papilomavirus 16 e7 humano. |
| PL3298033T5 (pl) | 2015-05-18 | 2023-10-30 | TCR2 Therapeutics Inc. | Kompozycje i zastosowania medyczne do reprogramowania TCR z zastosowaniem białek fuzyjnych |
| CN107748893A (zh) * | 2017-09-29 | 2018-03-02 | 阿里巴巴集团控股有限公司 | 提升车辆定损图像识别结果的方法、装置及服务器 |
| SG11202002635RA (en) | 2017-09-29 | 2020-04-29 | The United States Of America As Represented By The Secretary | Methods of isolating t cells having antigenic specificity for a p53 cancer-specific mutation |
| WO2019067243A1 (en) * | 2017-09-29 | 2019-04-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T CELL RECEPTORS RECOGNIZING P53 MUTE |
| JP2024517884A (ja) | 2021-05-07 | 2024-04-23 | アメリカ合衆国 | ｐ５３におけるＣ１３５Ｙ、Ｒ１７５Ｈ又はＭ２３７Ｉ変異を認識するＴ細胞受容体 |
| WO2024206274A2 (en) | 2023-03-27 | 2024-10-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors targeting y220c or r175h mutation in p53 |
-
2020
- 2020-06-26 TW TW114110844A patent/TW202525841A/zh unknown
- 2020-06-26 CN CN202080047882.0A patent/CN114341171A/zh active Pending
- 2020-06-26 EP EP20742583.6A patent/EP3990481A1/en active Pending
- 2020-06-26 KR KR1020227002872A patent/KR20220047969A/ko active Pending
- 2020-06-26 US US17/620,942 patent/US12479902B2/en active Active
- 2020-06-26 MX MX2021015877A patent/MX2021015877A/es unknown
- 2020-06-26 BR BR112021026408A patent/BR112021026408A2/pt unknown
- 2020-06-26 AU AU2020308004A patent/AU2020308004B2/en active Active
- 2020-06-26 WO PCT/US2020/039785 patent/WO2020264269A1/en not_active Ceased
- 2020-06-26 JP JP2021576970A patent/JP7635165B2/ja active Active
- 2020-06-26 TW TW109121744A patent/TWI908730B/zh active
- 2020-06-26 CA CA3144070A patent/CA3144070A1/en active Pending
-
2025
- 2025-02-12 JP JP2025020882A patent/JP2025081413A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022538148A5 (enExample) | ||
| JP2024517884A5 (enExample) | ||
| JP6993402B2 (ja) | 抗ｋｒａｓ－ｇ１２ｄ ｔ細胞受容体 | |
| Tan et al. | Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex | |
| JP2023159112A5 (enExample) | ||
| TWI908730B (zh) | 識別p53中之r175h或y220c突變之t細胞受體 | |
| JP2019502360A5 (enExample) | ||
| CN110357953B (zh) | 识别人巨细胞病毒pp65抗原的TCR | |
| JP2018510628A5 (enExample) | ||
| CN116693695A (zh) | 基于hla的方法和组合物及其用途 | |
| JP2019511214A5 (enExample) | ||
| CN109180787B (zh) | 靶向egfr抑制egf促肿瘤细胞增殖的多肽 | |
| KR20030084992A (ko) | 감소된 면역원성을 갖는 개질 인터페론 베타 | |
| JP2021528046A5 (enExample) | ||
| Tang et al. | A lncRNA Dleu2-encoded peptide relieves autoimmunity by facilitating Smad3-mediated Treg induction | |
| JP2023522512A5 (enExample) | ||
| CN110464840A (zh) | 一种肿瘤疫苗的制备方法及使用该方法制备的肿瘤疫苗 | |
| JP2004537284A5 (enExample) | ||
| IT202000006973A1 (it) | Antigeni herv tumore-specifici e loro uso nella immunoterapia del cancro | |
| CN116103233A (zh) | 肿瘤引流淋巴结抗原反应性cd8+t细胞的鉴定方法 | |
| JP2023540123A5 (enExample) | ||
| JPH05504955A (ja) | 白血病抑制因子 | |
| CA2425643A1 (en) | Cancer-linked genes as targets for chemotherapy | |
| AU2024311891A1 (en) | Antigen-specific t cell receptors and chimeric antigen receptors, and methods of use in immune signaling modulation for cancer immunotherapy | |
| CN115975943A (zh) | 基于acp5阳性t细胞的用于杀伤肿瘤的tcr-t细胞及其制备方法和应用 |